Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
837 Combination treatment with ATOR-4066, a Neo-X-Prime™ bispecific antibody targeting CD40 and CEACAM5, and anti-PD-1 reverses T cell exhaustion in vitro
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 837 Combination treatment with ATOR-4066, a Neo-X-Prime™ bispecific antibody targeting CD40 and CEACAM5, and anti-PD-1 reverses T cell exhaustion in vitro